In-vitro Fertilization Market Share

North America Market Analysis

The North America IVF market is the fastest growing and most technologically advanced in the global market. The region benefits from highly developed healthcare infrastructure, significant advancements in IVF technology, and a well-regulated medical industry. For instance, the U.S. FDA regulates drugs and devices used in IVF, followed by the implementation of the Fertility Clinic Success Rate and Certification Act by the CDC. Moreover, semen analysis and sperm function tests are high-complexity tests regulated by the Clinical Laboratory Improvement Amendments of 1988 (CLIA '88) in the U.S. Strict compliance with standards and on-site inspections are essential. Factors such as these make the North America market more reliable and investment-friendly.

The U.S. is the largest shareholder of the North America in-vitro fertilization market. Companies are strategically accelerating their businesses in the U.S. market to expand their footprint and impact on the market. For instance, in April 2023, US Fertility, and Ovation Fertility announced their agreement to combine and become the leading fertility company in the United States. This enhanced platform aimed to drive growth innovation and best practices to improve patient access, experience, and outcomes. Despite the high cost of treatment, the U.S. market growth is supported by technological innovations and awareness.

Canada in-vitro fertilization market is witnessing steady growth with rising demand for fertility treatments. Factors include infertility, delayed childbearing, and improved awareness of reproductive options. Furthermore, the Canadian healthcare system is known for its accessibility. Advances in reproductive technologies and increasing acceptance of ART are also propelling the market to grow further. In addition to the existing prominent players in the country, several numbers of IVF startups have also been recently launched, predicting significant growth for the country by 2037.

APAC Market Statistics

APAC in-vitro fertilization market is growing rapidly owing to the increasing infertility rates, delayed pregnancies, and the rising demand for advanced reproductive technologies. Primarily due to the increasing awareness of fertility treatments and expanding clinics across the region, the region is anticipated to witness further growth during the forecast period.  Several companies are launching products and initiatives to meet the demand for IVF treatments. For instance, in May 2023, Merck announced the launch of a new initiative, Fertility Counts, to address the challenges associated with low birth rates in the APAC region. It is intended to offer research and resources to support policymakers in identifying policy interventions that will be effective in building family-friendly societies.

Changing societal attitudes towards assisted reproduction is one of the prime driving factors for the India in-vitro fertilization market. India has recently become a hub for medical tourism, offering cost-effective IVF procedures with high success rates, and attracting patients from both domestic and international markets. Supportive government initiatives, an increasing number of fertility clinics, and advancements in IVF technology are further projected to boost the in-vitro fertilization market growth of the country. 

Owing to its large population and rapidly changing social norms around family planning, China is projected to witness considerable growth the relaxation of the one-child policy and the growing acceptance of ART have further fueled the demand for IVF treatments. Additionally, the rising trend of delayed pregnancies due to career-focused lifestyles, with increased infertility rates, is also boosting the in-vitro fertilization market in China. Government initiatives supporting reproductive health, and the availability of advanced IVF technologies is anticipated to drive the market further.